Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways

Immunology Letters

Volumn 121, Issue 1, 2008, Pages 22-26

  Sandri, Silvana ^a   Hatanaka, Elaine ^a,b   Franco, Andressa G ^a   Pedrosa, Alziana M C ^a   Monteiro, Hugo P ^c   Campa, Ana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CCL20; Mononuclear cells and serum amyloid A (SAA)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SERUM AMYLOID A;

ADAPTIVE IMMUNITY; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CHEMOKINE CCL20; FLAVONOIDS; HUMANS; IMIDAZOLES; LEUKOCYTES, MONONUCLEAR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 54049115029     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.07.013     Document Type: Article

References (32)

1. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
2. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
3. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265 (1999) 501-523
4. Urieli-Shoval S., Linke R.P., and Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 7 (2000) 64-69
5. Hatanaka E., Furlaneto C.J., Ribeiro F.P., Souza G.M., and Campa A. Serum amyloid A induced mRNA expression and release of tumor necrosis factor-alpha (TNF-α) in human neutrophils. Immunol Lett 91 (2004) 33-37
6. Ribeiro F.P., Furlaneto C.J., Hatanaka E., Ribeiro W.B., Souza G.M., and Cassatella M.A. Campa A. mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediat Inflamm 12 (2003) 173-178
7. Furlaneto C.J., and Campa A. A novel functions of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β e interleukin-8 by human blood neutrophils. Biochem Biophys Res Commun 268 (2000) 405-408
8. Hatanaka E., Ribeiro F.P., and Campa A. The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Micro 38 (2003) 81-84
9. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., and Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J Leukoc Biol 83 (2008) 1174-1180
10. Badolato R., Johnston J.A., Wang J.M., McVicar D., Xu L.L., Oppenheim J.J., et al. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 155 (1995) 4004-4010
11. Hatanaka E., Monteagudo P.T., Marrocos M.S., and Campa A. Interaction between serum amyloid A and leukocytes-a possible role in the progression of vascular complications in diabetes. Immunol Lett 108 (2007) 160-166
12. Kleeff J., Kusama T., Rossi D.L., Ishiwata T., Maruyama H., Friess H., et al. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 8 (1999) 650-657
13. Ruth J.H., Shahrara S., Park C.C., Morel J.C., Kumar P., Qin S., et al. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest 83 (2003) 579-588
14. Hosokawa Y., Nakanishi T., Yamaguchi D., Takahashi K., Yumoto H., and Matsuo T. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 128 (2002) 548-554
15. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Aït-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 (1998) 373-386
16. Liao F., Alderson R., Su J., Ullrich S.J., Kreider B.L., and Farber J.M. STRL22 is a receptor for the CC chemokine MIP-3alpha. Biochem Biophys Res Commun 236 (1997) 212-217
17. Dieu-Nosjean M.C., Vicari A., Lebecque S., and Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol 66 (1999) 252-262
18. Rossi D.L., Vicari A.P., Franz-Bacon K., McClanahan T.K., and Zlotnik A. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 158 (1997) 1033-1036
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 (1968) 77-89
20. Scapini P., Laudanna C., Pinardi C., Allavena P., Mantovani A., Sozzani S., et al. Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19. Eur J Immunol 31 (2001) 1981-1988
21. Schutyser E., Struyf S., Menten P., Lenaerts J.P., Conings R., Put W., et al. Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J Immunol 165 (2000) 4470-4477
22. Akahoshi T., Sasahara T., Namai R., Matsui T., Watabe H., Kitasato H., et al. Production of macrophage inflammatory protein 3alpha (MIP-3alpha) (CCL20) and MIP-3beta (CCL19) by human peripheral blood neutrophils in response to microbial pathogens. Infect Immun 71 (2003) 524-526
23. He R., Sang H., and Ye R.D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101 (2003) 1572-1581
24. Lee H.Y., Kim K.M., Park K.S., Shin E.H., Jo S.H., Kim S.D., et al. Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes. Mol Pharmacol 70 (2005) 241-248
25. He R., Shepard L.W., Chen J., Pan Z.K., and Ye R.D. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J Immunol 177 (2006) 4072-4079
26. Lee H.Y., Kim M.K., Park K.S., Bae Y.H., Yun J., Park J.I., et al. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun 330 (2005) 989-998
27. Chan H., Perussia B., Gupta J.W., Kobayashi M., Pospísil M., Young H.A., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173 (1991) 69-879
28. Kumon Y., Suehiro T., Hashimoto K., Nakatani K., and Sipe J.D. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 26 (1999) 785-790
29. Gutfeld O., Prus D., Ackerman Z., Dishon S., Linke R.P., Levin M., et al. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem 54 (2006) 63-73
30. Miida T., Yamada T., Seino U., Ito M., Fueki Y., Takahashi A., et al. Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta 1761 (2006) 424-433
31. Fyfe A.I., Rothenberg L.S., DeBeer F.C., Cantor R.M., Rotter J.I., and Lusis A.J. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96 (1997) 2914-2919
32. Yamada T., Kakihara T., Kamishima T., Fukuda T., and Kawai T. Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int 46 (1996) 797-800